Medical Condition News

RSS

Universal genetic testing may improve risk stratification and treatment for rare and lethal cancer

Esophageal adenocarcinoma (EAC) is a highly lethal cancer, with a five-year survival rate of less than 20 percent. Although a precursor lesion to EAC, called Barrett's esophagus (BE), is present in roughly seven percent of middle-aged adults, less than one percent of BE patients will progress to EAC, making it difficult to determine which individuals are at risk of developing this deadly cancer.

27 Jul 2023

People with Alzheimer's risk gene may lose ability to detect odors earlier

People who carry the gene variant associated with the strongest risk for Alzheimer's disease may lose their ability to detect odors earlier than people who do not carry the gene variant, which may be an early sign of future memory and thinking problems, according to a study published in the July 26, 2023, online issue of Neurology®, the medical journal of the American Academy of Neurology.

26 Jul 2023

Experts weigh benefits and risks of new Alzheimer's disease therapies

New therapies for early Alzheimer's disease, monoclonal antibodies that remove amyloid-β plaques in the brain, are bringing hope to people whose lives have been affected by the disease.

26 Jul 2023

Kundalini yoga may be beneficial for older women with Alzheimer's risk factors

Kundalini yoga, a form of yoga that focuses on breathing, meditation, and mental visualization, appeared beneficial for older women who had risk factors for Alzheimer's disease and concerns about episodes of memory decline, according to a UCLA Health study.

26 Jul 2023

Two infusions of IL-15-expressing CAR NK Cells boost survival in lymphoma mouse models

A new study led by researchers at The University of Texas MD Anderson Cancer Center discovered loss of metabolic fitness in chimeric antigen receptor (CAR) natural killer (NK) cells is a critical mechanism of resistance, with infused cells gradually losing the ability to compete with tumor cells for nutrients, leading to tumor relapse.

26 Jul 2023

More steps linked to improved health for heart failure patients

KIAA0930 could be a novel therapeutic target for cancer cachexia

A new research paper was published in Oncotarget's Volume 14 on July 20, 2023, entitled, "The uncharacterized transcript KIAA0930 confers a cachexic phenotype on cancer cells."

26 Jul 2023

Hypnosis offers new hope for people with spinal cord injury pain

Hypnosis was effective in helping people with recent spinal cord injuries learn coping strategies to fight chronic pain, a new study shows. Almost 90% of participants reported benefit from the treatment.

26 Jul 2023

Core promoter variation may drive development of triple-negative breast cancer

TNBC is a particularly aggressive subtype of breast cancer, characterized by the absence of three key receptors: estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2).

26 Jul 2023

American Heart Association grants $2.1 million to study migraines and cardiovascular disease

Existing research shows certain types of migraines can increase the risk of stroke, and there is growing evidence that they may also lead to other types of cardiovascular disease (CVD).

26 Jul 2023

Researchers discover potential new treatment for rhabdomyosarcoma

Researchers from the Leibniz Institute on Aging in Jena and the Brandenburg University of Technology Cottbus-Senftenberg have discovered a novel treatment approach for soft tissue tumors, which are frequently occurring in children and are often malignant.

26 Jul 2023

$Epileptika aims to help treat refractory epilepsy in people with intellectual disability$

Epileptika aims to help treat refractory epilepsy in people with intellectual disability

A team of researchers from the Universitat Politècnica de València (UPV) has participated in the development of Epileptika.

26 Jul 2023

Study finds gap in survival rates for Asian adults after out-of-hospital cardiac arrest

Despite similar rates of bystander CPR after an out-of-hospital cardiac arrest, Asian adults in the U.S. have lower rates of survival than white adults, according to new research published today in the Journal of the American Heart Association, an open access, peer-reviewed journal of the American Heart Association.

26 Jul 2023

Researchers make breakthrough in fight against mucosal melanoma

Although rare, mucosal melanoma in humans has a low survival rate. It has been difficult to investigate due to a lack of similar cancers in animals for study.

26 Jul 2023

Study highlights advantages of syphilis self-testing: convenience, privacy, and rapid results

Researchers performed a meta-analysis on the utility of syphilis self-testing (SST).

26 Jul 2023

Study reveals key mechanism linking obstructive sleep apnea and cardiovascular disease

Researchers have found that people with obstructive sleep apnea have an increased cardiovascular risk due to reduced blood oxygen levels, largely explained by interrupted breathing.

26 Jul 2023

Study sheds light on how breast cancer spreads to lymph nodes

Lymph nodes are one of the body's first lines of defense against disease. Immune cells are dispatched from these biological police stations to fight off intruders.

26 Jul 2023

MD Anderson and Nexo Therapeutics partner to advance new cancer therapies against previously undruggable targets

The University of Texas MD Anderson Cancer Center and Nexo Therapeutics today announced a multi-year strategic collaboration that aligns the innovative technology and capabilities of each organization at the earliest stages of drug discovery and development to rapidly advance impactful new cancer therapies against previously undruggable targets.

26 Jul 2023

Effects of turmeric supplementation in individuals with metabolic syndrome and diabetes

Study evaluated the effects of turmeric supplementation on glucose metabolism in patients with metabolic syndrome.

26 Jul 2023

Research uncovers new insights into post-COVID-19 syndrome (PCS) phenotypes and impact on quality of life

Researchers assessed post-coronavirus disease 2019 (COVID-19) syndrome (PCS) prevalence and severity.

26 Jul 2023

Medical Condition News

Universal genetic testing may improve risk stratification and treatment for rare and lethal cancer

People with Alzheimer's risk gene may lose ability to detect odors earlier

Experts weigh benefits and risks of new Alzheimer's disease therapies

Kundalini yoga may be beneficial for older women with Alzheimer's risk factors

Two infusions of IL-15-expressing CAR NK Cells boost survival in lymphoma mouse models

More steps linked to improved health for heart failure patients

KIAA0930 could be a novel therapeutic target for cancer cachexia

Hypnosis offers new hope for people with spinal cord injury pain

Core promoter variation may drive development of triple-negative breast cancer

American Heart Association grants $2.1 million to study migraines and cardiovascular disease

Researchers discover potential new treatment for rhabdomyosarcoma

Epileptika aims to help treat refractory epilepsy in people with intellectual disability

Study finds gap in survival rates for Asian adults after out-of-hospital cardiac arrest

Researchers make breakthrough in fight against mucosal melanoma

Study highlights advantages of syphilis self-testing: convenience, privacy, and rapid results

Study reveals key mechanism linking obstructive sleep apnea and cardiovascular disease

Study sheds light on how breast cancer spreads to lymph nodes

MD Anderson and Nexo Therapeutics partner to advance new cancer therapies against previously undruggable targets

Effects of turmeric supplementation in individuals with metabolic syndrome and diabetes

Research uncovers new insights into post-COVID-19 syndrome (PCS) phenotypes and impact on quality of life

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Latest News